Xenon Pharmaceuticals Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Xenon Pharmaceuticals Inc. on March 17, 2025, reporting events occurring on March 14, 2025. The company is incorporated in Canada and its common shares trade on The Nasdaq Global Market under the symbol XENE.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document.
Guidance, Outlook, and Other Events
Item 8.01 (Other Events) announces the meeting date, record date, and related information for the company's 2025 annual meeting of shareholders. This information was previously submitted to the System for Electronic Document Analysis and Retrieval (SEDAR+) in Canada. No guidance, outlook, risks, or contingencies are detailed in this specific filing.
Key Facts for Investors to Verify
- The specific date, time, and location of the 2025 annual meeting of shareholders.
- The record date for determining shareholder eligibility to vote.
- Details regarding the proxy statement or information circular filed with SEDAR+ (Exhibit 99.1).